Type2diabetes, SGLT2 Inhibitor, Urinary Tract Infection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Type2diabetes, SGLT2 Inhibitor, Urinary Tract Infection trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownNot Applicable

NCT05520684

Asymptomatic Bacteriuria, Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors and UTI Risk

The SGLT2 inhibitors have changed the treatment of type 2 diabetes mellitus in recent years, especially in patients with cardiovascular or renal disease. Howeve…

Turkey (Türkiye)120 participantsStarted 2022-02-15

Treatment: urine culture and urinalysis